- Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study2015 | Faculty of Medicine in Hradec Králové
- Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database2016 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Single-nucleotide Fc gamma receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma2021 | First Faculty of Medicine